Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Johnson & Johnson

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 23 December 2005:
Vol. 310. no. 5756, pp. 1890 - 1891
DOI: 10.1126/science.310.5756.1890a
Prev | Table of Contents | Next

News of the Week

DRUG TESTING:
Massive Trial of Celebrex Seeks to Settle Safety Concerns

Jennifer Couzin

Some experts are concerned that the design of a Pfizer-sponsored trial of Celebrex against two other popular anti-inflammatory painkillers, announced last week, could be tilted in favor of the COX-2 inhibitor and put patients at risk. (read more.)

Read the Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)